These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 10925332)
1. Low intracellular magnesium levels promote platelet-dependent thrombosis in patients with coronary artery disease. Shechter M; Merz CN; Rude RK; Paul Labrador MJ; Meisel SR; Shah PK; Kaul S Am Heart J; 2000 Aug; 140(2):212-8. PubMed ID: 10925332 [TBL] [Abstract][Full Text] [Related]
2. Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease. Shechter M; Merz CN; Paul-Labrador MJ; Kaul S J Am Coll Cardiol; 2000 Feb; 35(2):300-7. PubMed ID: 10676673 [TBL] [Abstract][Full Text] [Related]
3. Beneficial antithrombotic effects of the association of pharmacological oral magnesium therapy with aspirin in coronary heart disease patients. Shechter M; Merz CN; Paul-Labrador M; Meisel SR; Rude RK; Molloy MD; Dwyer JH; Shah PK; Kaul S Magnes Res; 2000 Dec; 13(4):275-84. PubMed ID: 11153897 [TBL] [Abstract][Full Text] [Related]
4. Plasma apolipoprotein B levels predict platelet-dependent thrombosis in patients with coronary artery disease. Shechter M; Bairey Merz CN; Paul-Labrador MJ; Shah PK; Kaul S Cardiology; 1999; 92(3):151-5. PubMed ID: 10754344 [TBL] [Abstract][Full Text] [Related]
6. The role of magnesium as antithrombotic therapy. Shechter M Wien Med Wochenschr; 2000; 150(15-16):343-7. PubMed ID: 11105330 [TBL] [Abstract][Full Text] [Related]
7. Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome. Bigalke B; Geisler T; Stellos K; Langer H; Daub K; Kremmer E; Seizer P; May AE; Lindemann S; Gawaz M Am Heart J; 2008 Jul; 156(1):193-200. PubMed ID: 18585516 [TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. Kowalski M J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863 [TBL] [Abstract][Full Text] [Related]
9. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease. Kitai T; Nishikawa M; Tanigawa T; Okinaka T; Wada H; Shiku H; Ikeda Y; Ito M; Isaka N; Nakano T Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480 [TBL] [Abstract][Full Text] [Related]
10. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure. Chung I; Choudhury A; Patel J; Lip GY Ann Med; 2009; 41(1):45-51. PubMed ID: 18618353 [TBL] [Abstract][Full Text] [Related]
11. Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease. Shechter M; Merz CN; Paul-Labrador M; Meisel SR; Rude RK; Molloy MD; Dwyer JH; Shah PK; Kaul S Am J Cardiol; 1999 Jul; 84(2):152-6. PubMed ID: 10426331 [TBL] [Abstract][Full Text] [Related]
12. Platelet P-selectin plays an important role in arterial thrombogenesis by forming large stable platelet-leukocyte aggregates. Yokoyama S; Ikeda H; Haramaki N; Yasukawa H; Murohara T; Imaizumi T J Am Coll Cardiol; 2005 Apr; 45(8):1280-6. PubMed ID: 15837262 [TBL] [Abstract][Full Text] [Related]
13. Platelet function following acute cerebral ischemia. Smout J; Dyker A; Cleanthis M; Ford G; Kesteven P; Stansby G Angiology; 2009; 60(3):362-9. PubMed ID: 19398427 [TBL] [Abstract][Full Text] [Related]
14. Comparison of early platelet activation in patients undergoing on-pump versus off-pump coronary artery bypass surgery. Ballotta A; Saleh HZ; El Baghdady HW; Gomaa M; Belloli F; Kandil H; Balbaa Y; Bettini F; Bossone E; Menicanti L; Frigiola A; Bellucci C; Mehta RH J Thorac Cardiovasc Surg; 2007 Jul; 134(1):132-8. PubMed ID: 17599498 [TBL] [Abstract][Full Text] [Related]
15. Effects of roxifiban on platelet aggregation and major receptor expression in patients with coronary artery disease for the Roxifiban Oral Compound Kinetics Evaluation Trial-I (ROCKET-I Platelet Substudy). Serebruany VL; Malinin AI; O'connor CM; Gurbel PA; Am Heart J; 2003 Jul; 146(1):91-8. PubMed ID: 12851613 [TBL] [Abstract][Full Text] [Related]
17. High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction. Lee KW; Blann AD; Lip GY Am J Hypertens; 2005 Jan; 18(1):104-15. PubMed ID: 15691624 [TBL] [Abstract][Full Text] [Related]
18. Comparison of platelet fibronectin, ADP-induced platelet aggregation and serum total nitric oxide (NOx) levels in angiographically determined coronary artery disease. Ekmekçi H; Işler I; Sönmez H; Gürel C; Ciftçi O; Ulutin T; Kökoğlu E; Domaniç N; Dirican A Thromb Res; 2006; 117(3):249-54. PubMed ID: 16378831 [TBL] [Abstract][Full Text] [Related]
19. Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting. Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Barrera-Ramirez C; Sabaté M; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Macaya C Thromb Res; 2005; 115(1-2):101-8. PubMed ID: 15567460 [TBL] [Abstract][Full Text] [Related]
20. Markers of low-grade inflammation and soluble cell adhesion molecules in Chinese patients with coronary artery disease. Fang L; Wei H; Mak KH; Xiong Z; Song J; Wang D; Lim YL; Chatterjee S Can J Cardiol; 2004 Dec; 20(14):1433-8. PubMed ID: 15614337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]